ReP USP - Resultado da busca

Filtros : "American Association of Pharmaceutical Scientists" Limpar

Filtros

Artigo de periodico
In vitro characterization of chitosan gels for buccal delivery of celecoxib: influence of a penetration enhancer (2012)
Cid, Yara Peluso; Pedrazzi, Vinícius; Sousa, Valéria Pereira de; Pierre, Maria Bernadete Riemma
Source: American Association of Pharmaceutical Scientists. Unidade: FORP
Subjects: PATOLOGIA BUCAL (TRATAMENTO), GEL (FORMAS FARMACÊUTICAS), QUITOSANA (TÉCNICAS;PERMEABILIDADE), MUCOSA ORAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CID, Yara Peluso et al. In vitro characterization of chitosan gels for buccal delivery of celecoxib: influence of a penetration enhancer. American Association of Pharmaceutical Scientists, v. 13, n. 1, p. 101-111, 2012Tradução . . Disponível em: https://doi.org/10.1208/s12249-011-9725-8. Acesso em: 04 jun. 2024.
APA
Cid, Y. P., Pedrazzi, V., Sousa, V. P. de, & Pierre, M. B. R. (2012). In vitro characterization of chitosan gels for buccal delivery of celecoxib: influence of a penetration enhancer. American Association of Pharmaceutical Scientists, 13( 1), 101-111. doi:10.1208/s12249-011-9725-8
NLM
Cid YP, Pedrazzi V, Sousa VP de, Pierre MBR. In vitro characterization of chitosan gels for buccal delivery of celecoxib: influence of a penetration enhancer [Internet]. American Association of Pharmaceutical Scientists. 2012 ; 13( 1): 101-111.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1208/s12249-011-9725-8
Vancouver
Cid YP, Pedrazzi V, Sousa VP de, Pierre MBR. In vitro characterization of chitosan gels for buccal delivery of celecoxib: influence of a penetration enhancer [Internet]. American Association of Pharmaceutical Scientists. 2012 ; 13( 1): 101-111.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1208/s12249-011-9725-8
Artigo de periodico
Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas (2012)
Löbenberg, Raimar; Bou-Chacra, Nadia Araci ; Stippler, Erika S; Shah, Vinod P; De Stefano, Anthony J; Hauck, Walter W; Williams, Roger L
Source: American Association of Pharmaceutical Scientists. Unidade: FCF
Assunto: BIOEQUIVALÊNCIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LÖBENBERG, Raimar et al. Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas. American Association of Pharmaceutical Scientists, v. 14, n. 3, p. 462-472, 2012Tradução . . Disponível em: https://doi.org/10.1208/s12248-012-9350-9. Acesso em: 04 jun. 2024.
APA
Löbenberg, R., Bou-Chacra, N. A., Stippler, E. S., Shah, V. P., De Stefano, A. J., Hauck, W. W., & Williams, R. L. (2012). Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas. American Association of Pharmaceutical Scientists, 14( 3), 462-472. doi:10.1208/s12248-012-9350-9
NLM
Löbenberg R, Bou-Chacra NA, Stippler ES, Shah VP, De Stefano AJ, Hauck WW, Williams RL. Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas [Internet]. American Association of Pharmaceutical Scientists. 2012 ; 14( 3): 462-472.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1208/s12248-012-9350-9
Vancouver
Löbenberg R, Bou-Chacra NA, Stippler ES, Shah VP, De Stefano AJ, Hauck WW, Williams RL. Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas [Internet]. American Association of Pharmaceutical Scientists. 2012 ; 14( 3): 462-472.[citado 2024 jun. 04 ] Available from: https://doi.org/10.1208/s12248-012-9350-9

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024